Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX)

31 filings reported holding RNTX - Rein Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2024.
Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4.61M shares of 23.6M outstanding shares and own 19.51% of the company stock.
Largest 10 shareholders include UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (1.4M shares), Alyeska Investment Group, L.P. (540K shares), Nantahala Capital Management, LLC (464K shares), VANGUARD GROUP INC (432K shares), Cable Car Capital LLC (420K shares), Prosight Management, LP (372K shares), Senvest Management, LLC (231K shares), GEODE CAPITAL MANAGEMENT, LLC (230K shares), Sigma Planning Corp (212K shares), and GAGNON SECURITIES LLC (71.8K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.